CIK 0001763950 · Non-accelerated filer<br>Smaller reporting company
Lantern Pharma Inc.
Sign in to watch- Ticker
- LTRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 463973463
- Phone
- 972-277-1136
- Business address
- 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
- Former names
- Lantern Pharma
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-27 | Fletcher Aaron G.L. 10% owner | Sale | −7,478 | $3.05 | $23K | 421,808 |
| 2025-05-27 | Fletcher Aaron G.L. 10% owner | Sale | −2,290 | $3.05 | $7K | 129,163 |
| 2025-05-27 | Kreis Leslie W. 10% owner | Sale | −3,790 | $3.05 | $12K | 213,763 |
| 2025-05-27 | Kreis Leslie W. 10% owner | Sale | −6,479 | $3.05 | $20K | 365,471 |
| 2025-05-27 | Kreis Leslie W. 10% owner | Sale | −1,000 | $3.05 | $3K | 56,467 |
| 2025-05-27 | Kreis Leslie W. 10% owner | Sale | −7,478 | $3.05 | $23K | 421,808 |
| 2025-05-27 | Kreis Leslie W. 10% owner | Sale | −2,290 | $3.05 | $7K | 129,163 |
| 2024-07-24 | KEYSER D JEFFREY Director | Option exercise | +3,832 | $3.13 | $12K | 0 |
| 2024-07-24 | KEYSER D JEFFREY Director | Option exercise · Series A Warrants | −3,832 | 0 | ||
| 2024-07-15 | Silberstein David S. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-07-15 | Silberstein David S. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-07-15 | SHARMA PANNA President and CEO | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-07-15 | Margrave David R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2024-07-15 | Maccecchini Maria-Luisa Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-07-15 | KEYSER D JEFFREY Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-07-15 | Chandru Vijay Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-07-15 | Chandru Vijay Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-07-15 | Bhatia Kishor G. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2024-05-24 | Kreis Leslie W. 10% owner | Sale | −1,859 | $6.33 | $12K | 57,467 |
| 2024-05-24 | Kreis Leslie W. 10% owner | Sale | −13,888 | $6.33 | $88K | 429,286 |
Page 5 of 13 · 245 trades